Medication info
Megalosartan Tablet (Losartan Potassium)

Megalosartan Tablet (Losartan Potassium)

Prescription medicationTabletOral
Ingredient · strength
Losartan Potassium›50mg / 1 tablet
Manufacturer / importer
LNC Bio Co., Ltd.
Appearance
White oval film-coated tablet
Packaging
30 tablets/bottle, 300 tablets/bottle
Approval status
Active

MFDS item code 202000343 · Approved 2020.01.21 · Insurance code 060500880

Summary

Main use
Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension
Who takes it
Adults · Children
Adult dose
This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, the dose may be increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered concomitantly with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger; for elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients receiving dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced intravascular effective blood volume For patients who may have reduced intravascular effective blood volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see section on precautions for use). 4) Patients with hepatic impairment A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.
Child dose
Pediatric and adolescent patients aged 6 years or older who weigh 20 kg or more but less than 50 kg and can swallow tablets: The recommended dose is 25 mg once daily. The dose may be increased to a maximum of 50mg once daily depending on the patient’s blood pressure response. Pediatric and adolescent patients aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg once daily. The dose may be increased to a maximum of 100 mg once daily depending on the patient’s blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Ingredients

Manufacturer
LNC Bio Co., Ltd.

Efficacy & effects

Treatment of hypertension and nephropathy in patients with type 2 diabetes mellitus and hypertension

  • Hypertension
  • nephropathy in patients with type 2 diabetes
View approved original text

This medication is used to treat hypertension. It also helps to slow the progression of nephropathy in patients with type 2 diabetes who have hypertension. It is effective in managing kidney complications associated with hypertension and diabetes.

How to take

Adult dose

This medicine may be taken with or without food, but it is recommended that it be taken at the same time each day. 1. Hypertension 1) Adults The recommended initial and maintenance dose is 50 mg of losartan potassium orally once daily. The maximum blood pressure-lowering effect is achieved 3 ∼ 6 weeks after starting treatment. If the treatment effect is insufficient, the same dose may be divided and administered orally twice daily, or, if necessary, the dose may be increased to 100 mg once daily. 3) If blood pressure is not controlled with this medicine alone, it may be administered concomitantly with another antihypertensive agent (e.g., a low-dose diuretic). An additive effect has been observed when administered concomitantly with hydrochlorothiazide. 2. Nephropathy in patients with type 2 diabetes and hypertension The usual adult dose is 50 mg of this medicine once daily. Depending on blood pressure, the dose may be increased to 100 mg once daily. However, an initial dose of 25 mg is recommended for patients at risk of excessive blood pressure reduction. This medicine may be administered concomitantly with insulin and commonly used antihyperglycemic agents (e.g., sulfonylureas, glitazones, glucosidase inhibitors). 3. Special patient populations 1) Elderly patients No adjustment of the initial dose is necessary in elderly patients 75 years of age or younger; for elderly patients over 75 years of age, an initial dose of 25 mg of this medicine once daily is recommended. 2) Patients with renal impairment (1) Creatinine clearance 20 ∼ 50 mL/min: No adjustment of the initial dose is necessary. (2) Creatinine clearance < 20 mL/min and patients receiving dialysis: An initial dose of 25 mg of this medicine once daily is recommended. 3) Patients with reduced intravascular effective blood volume For patients who may have reduced intravascular effective blood volume (e.g., patients being treated with diuretics), an initial dose of 25 mg of this medicine once daily is recommended (see section on precautions for use). 4) Patients with hepatic impairment A lower dose should be considered for patients with a history of hepatic impairment. Do not administer to patients with severe hepatic impairment.

Child dose

Pediatric and adolescent patients aged 6 years or older who weigh 20 kg or more but less than 50 kg and can swallow tablets: The recommended dose is 25 mg once daily. The dose may be increased to a maximum of 50mg once daily depending on the patient’s blood pressure response. Pediatric and adolescent patients aged 6 years or older who weigh 50 kg or more: The usual recommended dose is 50 mg once daily. The dose may be increased to a maximum of 100 mg once daily depending on the patient’s blood pressure response. Pediatric patients under 6 years of age: Not recommended. Pediatric patients with a glomerular filtration rate below 30 mL/min/1.73㎡: Not recommended. Pediatric patients with hepatic impairment: Not recommended.

Precautions

This medication can cause serious harm to the fetus if taken during pregnancy, particularly during the second and third trimesters, so it should not be taken by women who are pregnant or may become pregnant. It is safer not to administer this drug to patients with severely impaired liver function or specific hereditary diseases. Elderly patients, patients with weakened kidney function, and patients with hyperkalemia should use this drug cautiously and should have regular blood tests and condition checks as directed by their physician. This medication lowers blood pressure, and symptoms of hypotension or shock may appear; therefore, any symptoms should be reported to healthcare professionals immediately. Occasionally, serious side effects such as allergic reactions, angioedema, hepatitis, or worsening kidney function may occur, so if any unusual symptoms arise, the medication should be stopped immediately and healthcare professionals consulted. This drug may interact with specific medications, requiring caution when taken in conjunction with potassium-sparing diuretics, potassium supplements, lithium, and non-steroidal anti-inflammatory drugs (NSAIDs). While taking this medication, regular checks should be conducted on blood pressure, kidney function, and electrolyte status, especially for elderly patients or those with kidney disease. Women who are pregnant or breastfeeding should avoid taking this drug, and if it is necessary to take it, they must consult a physician first. This medication should not be given to children, especially to those under 6 years old or very young patients with severely impaired kidney function. Overdose may lead to hypotension and cardiac rhythm abnormalities, so the prescribed dosage must be adhered to, and immediate emergency treatment should be sought in case of an overdose. When taking this medication, symptoms such as dizziness or drowsiness may occur, requiring caution when driving or operating machinery. This medication should be kept out of the reach of children and should not be transferred to other containers.

Side effects

  • Craniosynostosis
  • anuria
  • hypotension
  • renal failure
  • death
  • muscle cramps
  • lower back pain
  • limb pain
  • dizziness
  • congestion
Show 133 more
  • upper respiratory infection
  • sinusitis
  • nausea
  • diarrhea
  • dyspepsia
  • cough
  • sinus disorder
  • pharyngitis
  • myalgia
  • insomnia
  • headache
  • weakness
  • fatigue
  • edema
  • swelling
  • abdominal pain
  • chest pain
  • lip swelling
  • eyelid swelling
  • facial rash
  • palm skin peeling
  • hemolysis
  • facial swelling
  • fever
  • orthostatic effects
  • syncope
  • angina
  • second-degree atrioventricular block
  • cerebrovascular accident
  • myocardial infarction
  • atrial fibrillation
  • arrhythmia
  • palpitations
  • bradycardia
  • tachycardia
  • ventricular tachycardia
  • ventricular fibrillation
  • anorexia
  • constipation
  • toothache
  • dry mouth
  • flatulence
  • gastritis
  • vomiting
  • anemia
  • gout
  • upper limb pain
  • hip joint pain
  • joint swelling
  • knee pain
  • musculoskeletal pain
  • shoulder pain
  • myotonia
  • arthralgia
  • arthritis
  • fibromyalgia
  • muscle weakness
  • anxiety
  • anxiety disorder
  • ataxia
  • confusion
  • depression
  • nightmares
  • sensory loss
  • diminished libido
  • memory impairment
  • migraine
  • hyperesthesia
  • sensory disturbance
  • peripheral neuropathy
  • panic disorder
  • sleep disorder
  • hypersomnia
  • tremor
  • dyspnea
  • bronchitis
  • pharyngeal discomfort
  • epistaxis
  • rhinitis
  • respiratory congestion
  • chest discomfort
  • hair loss
  • dermatitis
  • skin dryness
  • petechiae
  • erythema
  • flushing
  • photosensitivity reaction
  • pruritus
  • rash
  • sweating
  • urticaria
  • blurred vision
  • burning eyes
  • pain
  • conjunctivitis
  • dysgeusia
  • tinnitus
  • vision impairment
  • erectile dysfunction
  • nocturia
  • frequency
  • urethral infection
  • vascular edema
  • vasculitis
  • anaphylactoid syndrome
  • liver dysfunction
  • hepatitis
  • intestinal vascular edema
  • lethargy
  • thrombocytopenia
  • elevated creatine kinase
  • rhabdomyolysis
  • acute renal failure
  • dry cough
  • erythematous skin disease
  • hyperkalemia
  • hyponatremia
  • elevated ALT
  • increased BUN
  • elevated serum creatinine
  • decreased hemoglobin
  • decreased hematocrit
  • elevated liver enzymes
  • increased serum bilirubin
  • syncope
  • loss of consciousness
  • acute hepatitis
  • fulminant hepatitis
  • ventricular ectopic beat
  • hypoglycemia
  • tachycardia
  • hypotension

Not everyone experiences these, and they can vary from person to person.

Storage

This medication must be stored in a tightly closed container to protect it from exposure to air or moisture. It is recommended to maintain a storage temperature between 1°C and 30°C.

Appearance and packaging

Appearance

White oval film-coated tablet

Package unit

30 tablets/bottle, 300 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.